Abeona Therapeutics Inc banner

Abeona Therapeutics Inc
NASDAQ:ABEO

Watchlist Manager
Abeona Therapeutics Inc Logo
Abeona Therapeutics Inc
NASDAQ:ABEO
Watchlist
Price: 6.01 USD 3.09% Market Closed
Market Cap: $342.9m

Intrinsic Value

ABEO doesn't have a meaningful market cap.

The intrinsic value for Abeona Therapeutics Inc (ABEO) under the Base Case is 12.49 USD. Compared with the current market price of 6.01 USD, the stock appears Undervalued by 52% .

Based on two methods:

DCF suggests undervaluation, while multiples suggest overvaluation.

ABEO Intrinsic Value
12.49 USD
Undervaluation 52%
Intrinsic Value
Price $6.01
Bear Case
Base Case
Bull Case
Monitor ABEO
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value $9.99
Get notified when the price drops into your buy zone
Intrinsic Value $12.49
Margin of Safety 20% $9.99
Current Price $6.01
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
Ask AI Assistant
What other research platforms think about ABEO?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is ABEO valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Abeona Therapeutics Inc.

Explain Valuation
Alternatives to ABEO

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

ABEO Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one ABEO stock?

The intrinsic value for Abeona Therapeutics Inc (ABEO) under the Base Case is 12.49 USD.

Is ABEO stock undervalued or overvalued?

Compared with the current market price of 6.01 USD, the stock appears Undervalued by 52% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett